Considerations for Clinical Therapeutic Development of Statins for Neurodevelopmental Disorders

eNeuro. 2020 Mar 6;7(2):ENEURO.0392-19.2020. doi: 10.1523/ENEURO.0392-19.2020. Print 2020 Mar/Apr.

Myrthe J Ottenhoff¹, Lianne C Krab^{2

3

4}, Ype Elgersma⁵

¹ Department of Neuroscience, ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus Medical Center, 3015 GD, Rotterdam, The Netherlands.
² Cordaan Outpatient Clinic for ID Medicine, 1033 PK, Amsterdam.
³ Odion Outpatient Clinic for ID Medicine, 1531 AD, Wormer.
⁴ Department of Pediatrics, Amsterdam UMC, 1105 AZ, Amsterdam, The Netherlands.
⁵ Department of Neuroscience, ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus Medical Center, 3015 GD, Rotterdam, The Netherlands y.elgersma@erasmusmc.nl.

No abstract available

Keywords: autism spectrum disorder; cognitive trials; fragile X; lovastatin, RASopathies; simvastatin.

MeSH terms